SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer

Progress in emerging therapies for advanced prostate cancer

(2012) Stéphane Oudard   CANCER TREATMENT REVIEWS

A transcriptional repressor co-regulatory network governing androgen response in prostate cancers

(2012) Kern Rei Chng et al.   EMBO JOURNAL

SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice

(2012) Fahad Zadjali et al.   FASEB JOURNAL

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression

(2012) J. M. Drake et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer

(2011) Sead Crnalic et al.   Acta Orthopaedica

Cancer risk in hyperprolactinemia patients: a population-based cohort study

(2011) Katarina Berinder et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Tumor Expression of Human Growth Hormone and Human Prolactin Predict a Worse Survival Outcome in Patients with Mammary or Endometrial Carcinoma

(2011) Zheng-Sheng Wu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Global quantification of mammalian gene expression control

(2011) Björn Schwanhäusser et al.   NATURE

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

(2011) Emma Hörnberg et al.   PLoS One

The SOCS2 Ubiquitin Ligase Complex Regulates Growth Hormone Receptor Levels

(2011) Mattias Vesterlund et al.   PLoS One

Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans

(2011) J. Guevara-Aguirre et al.   Science Translational Medicine

Prostate cancer and acromegaly

(2010) Lívia L. Corrêa et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression

(2010) Jindan Yu et al.   CANCER CELL

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines

(2010) Honglin Chen et al.   ENDOCRINE-RELATED CANCER

An update on androgen deprivation therapy for prostate cancer

(2010) Nima Sharifi et al.   ENDOCRINE-RELATED CANCER

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

(2010) V. Rouet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression

(2010) Kiyoshi Takahara et al.   PROSTATE

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

(2009) Qianben Wang et al.   CELL

Cocoa Butter and Safflower Oil Elicit Different Effects on Hepatic Gene Expression and Lipid Metabolism in Rats

(2009) Carolina Gustavsson et al.   LIPIDS

Ezrin mediates c-Myc actions in prostate cancer cell invasion

(2009) Y-C Chuan et al.   ONCOGENE

SOCS2 Influences LPS Induced Human Monocyte-Derived Dendritic Cell Maturation

(2009) Jin Hu et al.   PLoS One

An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines

(2008) Miltiadis Paliouras et al.   BIOLOGICAL CHEMISTRY

Src as a therapeutic target in men with prostate cancer and bone metastases

(2008) Fred Saad   BJU INTERNATIONAL

Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells

(2008) S.-H. Tan et al.   CANCER RESEARCH

Mechanisms mediating androgen receptor reactivation after castration

(2008) Xin Yuan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Disruption of Growth Hormone Signaling Retards Prostate Carcinogenesis in the Probasin/TAg Rat

(2007) Zhuohua Wang et al.   ENDOCRINOLOGY